10-Nitrooleic acid|CAS 875685-46-4|DC Chemicals

Cas No.:	875685-46-4
Chemical Name:	10-Nitro Oleic Acid
Synonyms:	10-Nitro Oleic Acid;9-Octadecenoic acid, 10-nitro-, (9E)-;PLURIPOTIN;(e)-10-Nitrooctadec-9-enoate;SR-01000946993;SCHEMBL1018141;10-nitrooleic acid;10-Nitrooleate;HY-101559;Q27159052;875685-46-4;DTXSID401347887;(E)-10-nitrooctadec-9-enoic acid;9-Octadecenoic acid, 10-nitro-;10-nitro-oleic acid;10-nitro-9-trans-octadecenoic acid;1N19AGY57Y;Oa-NO2;10-Nitro-9(E)-octadec-9-enoic acid;(9E)-10-nitrooctadecenoic acid;BDBM50295049;NS00096553;CHEBI:86285;LMFA01120003;F70901;LNA;CXA-10;(9E)-10-nitrooctadec-9-enoic acid;(9E)-10-Nitrooctadecenoate;10-nitro-9E-Octadecenoate;88127-53-1;10-nitroelaidic acid;UNII-1N19AGY57Y;WRADPCFZZWXOTI-BMRADRMJSA-N;CHEMBL561371;E-10-nitrooleic acid;DB15026;CS-0021707;A903619;10-nitro-9E-octadecenoic acid;SR-01000946993-1;9-nitro-9-trans-Octadecenoic Acid;E-10-NO2-18:1;10-Nitroelaidate;AKOS040748198;DB-250212
SMILES:	[O-][N+](/C(=C/CCCCCCCC(=O)O)/CCCCCCCC)=O
Formula:	C₁₈H₃₃NO₄
M.Wt:	327.458925962448
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.